Skip to main content
. 2021 Aug 20;10(16):3709. doi: 10.3390/jcm10163709

Table 4.

Comparison of immunophenotype responses to radical prostatectomy performed by the open or laparoscopic technique.

Open Radical Prostatectomy
Subset PreOp (Cells/µL)
Median (Range)
Three Months (Cells/µL) Median (Range) p Value Trend
CD3+ 1280 (878–2086) 1538 (924–1956) 0.84
CD4+ 826 (549–1400) 839 (630–1162) 0.72
CD8+ 554 (298–928) 711 (423–958) 0.15
Ratio CD4+/CD8+ 1.7 (1.2–2.4) 1.5 (0.8–2.0) 0.07
CD8+CD69+ 169 (92–347) 198 (159–261) 0.26
Ratio CD4+/CD8+CD69+ 4.5 (2.9–6.9) 4.3 (3.0–7.0) 0.16
CD4+CD25+FoxP3+ 3.4 (2.1–6.8) 3.5 (2.1–4.8) 0.30.
CD3-CD16+CD56+ 205 (106–329) 294 (170–441) 0.03
MDSC 11.1 (4.7–16.0) 14.8 (10.5–26.1) <0.01
CD19+ 188 (124–299) 180.735 (147–272) 0.74
Laparoscopic Radical Prostatectomy
Subset PreOp (Cells/µL)
Median (Range)
Three Months (Cells/µL) Median (Range) p Value Trend
CD3+ 1292 (964−1867) 1346 (1126–1984) <0.05
CD4+ 780 (651–1282) 881 (696–1187) 0.46
CD8+ 538 (379–780) 576 (437–904) <0.001.
Ratio CD4+/CD8+ 1.8 (1.1–2.4) 1.7 (0.9–2.3) 0.10
CD8+CD69+ 209 (131–330) 216 (152–322) 0.15
Ratio CD4+/CD8+CD69+ 4.0 (2.7–6.1) 4.2 (3.0–6.3) 0.10
CD4+CD25+FoxP3+ 2.37 (1.1–4.6) 2.5 (1.2–4.1) 0.91
CD3-CD16+CD56+ 223 (117–353) 359 (199–502) <0.001
MDSC 11.0 (6.4–14.9) 11.2 (7.4–21.7) 0.16
CD19+ 187 (119–307) 185 (131–273) 0.50

Symbols in Table 4: “≈”—no significant change; “↑”—increase.